Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
20,01 USD | -2,63% | -13,82% | -11,58% |
Attività
Numero di dipendenti: 51
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Benjamin Dake
FOU | Founder | 48 | 27/07/18 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 01/02/21 |
George Eldridge
DFI | Director of Finance/CFO | 61 | 01/03/21 |
Marco Verwijs
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Hunter Gillies
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/20 |
Ralph Niven
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/07/20 |
Timothy Pigot
PRN | Corporate Officer/Principal | - | 01/06/21 |
Sue Fischer
PRN | Corporate Officer/Principal | - | - |
Donna Dea
LAW | General Counsel | - | 01/09/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Donald Santel
BRD | Director/Board Member | 62 | 19/01/23 |
Maha Katabi
BRD | Director/Board Member | 50 | 01/08/20 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 01/02/21 |
Dave Grayzel
BRD | Director/Board Member | 56 | 01/08/20 |
Mark Iwicki
BRD | Director/Board Member | 57 | 01/02/21 |
Joshua Resnick
BRD | Director/Board Member | 49 | 01/10/18 |
Allison Dorval
BRD | Director/Board Member | 48 | 15/07/21 |
Habib Dable
CHM | Chairman | 54 | 10/07/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 28 737 381 | 28 728 904 ( 99,97 %) | 0 | 99,97 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-11,58% | 575 Mln | |
+0,17% | 42,19 Mrd | |
+44,30% | 40,15 Mrd | |
-6,20% | 28,31 Mrd | |
+5,23% | 24,63 Mrd | |
-24,79% | 18,2 Mrd | |
+26,69% | 12,01 Mrd | |
-3,13% | 11,76 Mrd | |
+6,57% | 10,4 Mrd | |
-18,08% | 9,94 Mrd |
- Borsa valori
- Azioni
- Azione AVTE
- Società Aerovate Therapeutics, Inc.